1Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression [J]. Cancer Res, 1997,57(21) :4749-4756.
2Coleman WB, Tsongalis GJ. The role of genomic instability in human carcinogenesis [J]. Anticancer Res, 1999,19 (6A):4645 -4664.
3Boland CR, Thibodeau SN, Hamilton SR, et al. A national Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer [J]. Cancer Res, 1998,58(22): 5248-5257.
4Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch repair protein expression in hereditary and sporadic colorectal carcinogenesis [J]. Cancer Res,2001,61 (3): 896-899.
5Jacob S, Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis [ J ]. Biochimie, 2002,84 ( 1 ): 27-47.
6Lynch HT, da la Chapelle A. Genetic susceptibility to nonpolyposis colorectal cancer [J]. J Med Genet, 1999,36( 11 ): 801-818.
7Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer [J]. J Clin Oncol, 2000,18(19) :2193-2200.
8Lim PC, Tester D, Cliby W, et al. Absence of mutation in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability [J]. Clin Cancer Res, 1996,2(11): 1907-1911.
9Merlo A, Herman JG, Mao L, et al. 5'-CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers [J].Nat Med, 1995,1 (7): 686-692.
5Hashimoto M, Asahina Y, Sano J, et al. Cloning of canine Toll-like receptor 9 and its expression in dog tissues[J]. Vet Immunol Immunop, 2005,106:159-163.
6Wu C C, Sabet M, Hayashi T, et al. In vivo efficacy of a phosphodiester TLR- 9 aptamer and its beneficial effect in a pulmonary anthrax infection model[J]. Cell Immunol, 2008,251: 78-85.
7Rifkin I R, Leadbetter E A, Busconi L, et al. Toll-like receptors, endogenous ligands, and systemic autoimmune disease [J]. Immunol Rev, 2005,204:27-42.
8Rayburn E R, Wang W, Zhang R, et al. Experimental therapy for colon cancer: anti- cancer effects of TLR9 agonism, combination with other therapeuticmodalities, and dependence upon p53[J]. Int J Oncol, 2007,30:1511-1519.
9Nagai M, Nakamura A, Makina R, et al. Expression of DNA (5-cytosin) -methyltransferases (DNMTs) in hepa- to-cellular carcinomas[J]. Hepatol Res, 2003,26 ( 3 ) : 186.
10Ahmed IA, Pusch CM, Hamed T, et al. Epigenetic altera- tions by methylation of RASSF1A and DAPK1 promoter sequences in manmary carcinoma detected in extracellular tumor DNA[J]. Cancer Genet Cytogenet, 2010, 199 (2) : 96.
